HALO logo
halo search icon
Cybin, Inc.

US$4.34

Price Change Indicator
0.16 (3.83%)
Cybin, Inc.
HELP · NAS

Cybin, Inc.

Start Trading HELP for Free

US$4.34

Price Arrow0.16 (3.83%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Cybin, Inc. Overview

HELP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About HELP

icon

Website

Cybin, Inc.

icon

Telephone

1.908.764.8385

icon

Address

Suite 5600, 100 King Street West, Toronto, ON M5X 1C9

Description

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

HELP Price Chart

Key Stats

Market Cap

US$1.39M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.15 - 9.83

Trade Value (12mth)

US$1,210,997.00

1 week

-10.49%

1 month

-15.21%

YTD

-49.52%

1 year

-40.46%

All time high

128.44

Key Fundamentals

EPS 3 yr Growth

-44.40%

EBITDA Margin

0.00%

Operating Cashflow

-$74m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

43m

HALO Sector

Healthcare

Next Company Report Date

01-Jul-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

HELP Announcements

Latest Announcements

DateAnnouncements
05 May 26
01 May 26
29 April 26
24 April 26
21 April 26

HELP Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-2.89-4.02-4.09locklocklock
EPS (Fully Diluted)
 $locklocklocklock-2.89-4.02N/Alocklocklock
Growth
 %locklocklocklock60.7-39-1.8locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Cybin, Inc. (HELP:NAS)?
Halo FAQ
The current share price of Cybin, Inc. (HELP:NAS) is USD$4.34.
What is the 52-week high share price for Cybin, Inc. (HELP:NAS)?
Halo FAQ
The 52-week high share price for Cybin, Inc. (HELP:NAS) is USD$9.83.
What is the 52-week low share price for Cybin, Inc. (HELP:NAS)?
Halo FAQ
The 52-week low share price for Cybin, Inc. (HELP:NAS) is USD$4.15.
What is the dividend yield for Cybin, Inc. (HELP:NAS)?
Halo FAQ
Cybin, Inc. (HELP:NAS) does not pay a dividend.
What was Cybin, Inc. (HELP:NAS) last dividend payment?
Halo FAQ
Cybin, Inc. (HELP:NAS) does not pay a dividend.
What is the franking level for Cybin, Inc. (HELP:NAS)?
Halo FAQ
Cybin, Inc. (HELP:NAS) has a franking level of 0.00%.
In which sector is Cybin, Inc. (HELP:NAS) classified?
Halo FAQ
Cybin, Inc. (HELP:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial